Hosted on MSN8h
Protesters gather in lower Manhattan to denounce recent ICE activity in New York City
Protesters took to the streets of lower Manhattan to denounce and protest U.S. Immigration and Customs Enforcement (ICE) on ...
Record-high vacancies aren't stopping construction of new office buildings
The Boston area began 2025 with a record-high office vacancy rate of 17%. Yet there are at least seven notable office ...
Summerlin offers homes ready for immediate occupancy
The Summerlin master-planned community offers more than 75 unique floor plans in 15 neighborhoods throughout eight distinct ...
VP Vance, Ohio leaders visit East Palestine train derailment site
Bianca Censori has been romantically linked to Ye, the rapper formerly known as Kanye West, since 2023. Chesley "Sully" ...
Amo says Trump’s DEI remarks on plane crash ‘beneath the office of the president’
Rep. Gabe Amo (D-R.I.) on Sunday criticized President Trump for tying diversity, equity and inclusion (DEI) hiring practices ...
The Patriot Ledger14d
FDA approves first new non-opioid painkiller in decades, and it's from a MA company.
Vertex Pharmaceuticals is a biotech company based in Boston. Its headquarters are in the Seaport neighborhood, and it also has a research site in Cambridge's Kendall Square. The company also has ...
Wall Street Journal14d
Vertex Pharmaceuticals Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Hosted on MSN14d
Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller
Vertex Pharmaceuticals won FDA approval for its non-opioid painkiller Journavx. Vertex stock jumped in late trading.
kcra.com15d
FDA approves new pain drug Journavx as opioid alternative
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals' Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach to ...